JP Morgan Starts KERX at Overweight; Adds to Focus List
Tweet Send to a Friend
JP Morgan initiates coverage on Keryx Biopharma (Nasdaq: KERX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
